Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study

Bone marrow derived mesenchymal stromal cells (BM-MSCs) have emerged as a possible new therapy for Multiple Sclerosis (MS), however studies regarding efficacy and in vivo immune response have been limited and inconclusive. We conducted a phase I clinical study assessing safety and clinical and perip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Iacobaeus, Ellen, Kadri, Nadir, Lefsihane, Katia, Boberg, Erik, Gavin, Caroline, Törnqvist Andrén, Anton, Lilja, Anders, Brundin, Lou, Blanc, Katarina Le
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947442/
https://ncbi.nlm.nih.gov/pubmed/31810187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8122102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados